Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: BLACKSMITH MEDICINES, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-09-21 to 2023-12-20
Current total value of award: $4712500
Description: FG-2101: A FIRST-IN-CLASS LPXC INHIBITOR FOR THE TREATMENT OF MDR GRAMNEGATIVE URINARY TRACT INFECTIONS.